SCHEMBL21362658

SCHEMBL21362658

CC(c1ccc(C(=O)c2ccc(F)cc2)c(Br)c1)N(C)C(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 2/20 0.35
MAPK14 Q16539 2/20 0.34
KMT2A Q03164 2/20 0.34
LMNA P02545 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
ALDH1A1 P00352 3/20 0.33
ALPG P10696 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
CNR2 P34972 1/20 0.32
ELANE P08246 1/20 0.32
SSTR4 P31391 1/20 0.31
HPGD P15428 2/20 0.31
USP2 O75604 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
APP P05067 1/20 0.31
TXNRD1 Q16881 1/20 0.31
LTC4S Q16873 1/20 0.31
ATM Q13315 1/20 0.30
BACE1 P56817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21351900 0.78 CNR2 (0.35) KMT2ALMNASMN1; SMN2ALDH1A1ALPG
SCHEMBL20157564 0.77 LMNA (0.42) MAPK14KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL20158053 0.74 C5AR1 (0.36) LMNAALDH1A1CNR2HTT
SCHEMBL20157556 0.74 LMNA (0.44) KMT2ALMNASMN1; SMN2ALDH1A1ALPG
SCHEMBL20158052 0.73 LMNA (0.39) MAPK14KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL23318417 0.72 ALOX5 (0.49) AAK1KMT2ALMNASMN1; SMN2TDP1
SCHEMBL22946389 0.72 ALOX5 (0.49) AAK1KMT2ALMNASMN1; SMN2TDP1
SCHEMBL17041586 0.72 TRPM8 (0.37) AAK1APP
SCHEMBL29531722 0.72 ALOX5 (0.49) AAK1KMT2ALMNASMN1; SMN2TDP1
SCHEMBL21362448 0.72 ABCC9 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed